CompletedPhase 3

Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

NCT00381472

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Birmingham, Alabama, United States

+75 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2003-06
Enrollment: 393 participants
Sponsor: GlaxoSmithKline
Purpose: treatment

Locations (76)

GSK Investigational SiteBirmingham, Alabama, United States
GSK Investigational SiteNorthridge, California, United States
GSK Investigational SiteSan Francisco, California, United States
GSK Investigational SiteEnglewood, Colorado, United States
GSK Investigational SiteBoca Raton, Florida, United States
GSK Investigational SitePanama City, Florida, United States
GSK Investigational SiteSt. Petersburg, Florida, United States
GSK Investigational SiteTampa, Florida, United States
GSK Investigational SiteAtlanta, Georgia, United States
GSK Investigational SiteAtlanta, Georgia, United States
GSK Investigational SiteAugusta, Georgia, United States
GSK Investigational SiteGlenview, Illinois, United States
GSK Investigational SiteKansas City, Kansas, United States
GSK Investigational SiteBoston, Massachusetts, United States
GSK Investigational SiteBingham Farms, Michigan, United States
GSK Investigational SiteSouthfield, Michigan, United States
GSK Investigational SiteTraverse City, Michigan, United States
GSK Investigational SiteLas Vegas, Nevada, United States
GSK Investigational SiteAlbany, New York, United States
GSK Investigational SiteNew York, New York, United States
GSK Investigational SiteCharlotte, North Carolina, United States
GSK Investigational SiteDurham, North Carolina, United States
GSK Investigational SiteRaleigh, North Carolina, United States
GSK Investigational SiteToledo, Ohio, United States
GSK Investigational SitePhiladelphia, Pennsylvania, United States
GSK Investigational SiteUpland, Pennsylvania, United States
GSK Investigational SiteWichita Falls, Texas, United States
GSK Investigational SiteMilwaukee, Wisconsin, United States
GSK Investigational SiteAntwerp, Belgium
GSK Investigational SiteEdegem, Belgium
GSK Investigational SiteHasselt, Belgium
GSK Investigational SiteLeuven, Belgium
GSK Investigational SiteRoeselare, Belgium
GSK Investigational SiteBrno, Czechia
GSK Investigational SiteHradec Králové, Czechia
GSK Investigational SiteOstrava, Czechia
GSK Investigational SiteOstrava, Czechia
GSK Investigational SitePardubice, Czechia
GSK Investigational SitePilsen, Czechia
GSK Investigational SitePrague, Czechia
GSK Investigational SitePrague, Czechia
GSK Investigational SitePrague, Czechia
GSK Investigational SiteAix-en-Provence, France
GSK Investigational SiteLille, France
GSK Investigational SiteParis, France
GSK Investigational SitePoitiers, France
GSK Investigational SiteBochum, North Rhine-Westphalia, Germany
GSK Investigational SiteLeipzig, Saxony, Germany
GSK Investigational SiteBudapest, Hungary
GSK Investigational SiteBudapest, Hungary
GSK Investigational SiteBudapest, Hungary
GSK Investigational SiteBudapest, Hungary
GSK Investigational SiteBudapest, Hungary
GSK Investigational SiteMiskolc, Hungary
GSK Investigational SiteMiskolc, Hungary
GSK Investigational SitePécs, Hungary
GSK Investigational SiteVasvari Pal Street 2, H=9023 Gyor, Hungary
GSK Investigational SitePozzilli (IS), Molise, Italy
GSK Investigational SiteTurin, Piedmont, Italy
GSK Investigational SiteGrosseto, Tuscany, Italy
GSK Investigational SiteLido Di Camaiore (LU), Tuscany, Italy
GSK Investigational SiteVicenza, Veneto, Italy
GSK Investigational SiteBialystok, Poland
GSK Investigational SiteCibórz, Poland
GSK Investigational SiteGdansk, Poland
GSK Investigational SiteGdansk, Poland
GSK Investigational SiteKatowice, Poland
GSK Investigational SiteKrakow, Poland
GSK Investigational SiteLeszno, Poland
GSK Investigational SiteLublin, Poland
GSK Investigational SiteLublin, Poland
GSK Investigational SiteSzwajcarska 3, Poland
GSK Investigational SiteTorun, Poland
GSK Investigational SiteWarsaw, Poland
GSK Investigational SiteWarsaw, Poland
GSK Investigational SiteBarcelona, Spain